Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells

A new Science Translational Medicine paper is first to report how editing a portion of stem cells with CRISPR/Cas9 is sufficient for long-term reactivation of therapeutic hemoglobin
Releases - July 31, 2019

One step closer to the Berlin Patient and an HIV cure

Kiem Lab, Clinical Research Division and Vaccine and Infections Disease Division
Science Spotlight - June 18, 2018

Gene editing shows promise for sickle cell and related disorders

Preclinical results offer new hope in group of dangerous inborn diseases
Hutch News - May 23, 2018

Gene editing holds promise for shrinking HIV ‘reservoir’

Study mimicking Timothy Ray Brown’s HIV-resistant mutation led to fewer latently infected cells — a key step toward driving the virus into remission without the need for antivirals
Hutch News - April 25, 2018
Last Modified, August 15, 2019